Damian Harding

730 total citations
9 papers, 159 citations indexed

About

Damian Harding is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Damian Harding has authored 9 papers receiving a total of 159 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Hepatology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Damian Harding's work include Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (3 papers) and Microbial Metabolites in Food Biotechnology (1 paper). Damian Harding is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (3 papers) and Microbial Metabolites in Food Biotechnology (1 paper). Damian Harding collaborates with scholars based in Australia, United Kingdom and Denmark. Damian Harding's co-authors include M. Thamara P. R. Perera, Frederick Chen, Dhiraj Tripathi, Simon Olliff, Gerry MacQuillan, Nick Murphy, William Bernal, Nigel Heaton, Roger Williams and Fin Stolze Larsen and has published in prestigious journals such as Journal of Clinical Oncology, World Journal of Gastroenterology and The Medical Journal of Australia.

In The Last Decade

Damian Harding

9 papers receiving 157 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Damian Harding Australia 6 125 113 43 26 11 9 159
Alisa Likhitsup United States 9 132 1.1× 158 1.4× 43 1.0× 15 0.6× 11 1.0× 32 252
Sonia Berardi Italy 9 132 1.1× 114 1.0× 117 2.7× 14 0.5× 3 0.3× 19 225
Laura Cisneros Mexico 4 133 1.1× 87 0.8× 57 1.3× 22 0.8× 3 0.3× 9 184
Kate D. Lynch Australia 5 56 0.4× 70 0.6× 34 0.8× 11 0.4× 5 0.5× 23 123
Zeeshan Ahmad Wani India 5 108 0.9× 102 0.9× 18 0.4× 25 1.0× 3 0.3× 14 153
Sandra Saldana Mexico 2 100 0.8× 64 0.6× 51 1.2× 31 1.2× 5 0.5× 5 205
Amol S. Rangnekar United States 10 168 1.3× 143 1.3× 80 1.9× 56 2.2× 2 0.2× 28 273
Sheila Eswaran United States 9 137 1.1× 196 1.7× 60 1.4× 13 0.5× 17 1.5× 27 298
H. H. Dahm Germany 5 156 1.2× 142 1.3× 100 2.3× 37 1.4× 5 0.5× 7 249
Miquel Sanz Spain 5 81 0.6× 47 0.4× 46 1.1× 19 0.7× 14 1.3× 6 119

Countries citing papers authored by Damian Harding

Since Specialization
Citations

This map shows the geographic impact of Damian Harding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damian Harding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damian Harding more than expected).

Fields of papers citing papers by Damian Harding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damian Harding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damian Harding. The network helps show where Damian Harding may publish in the future.

Co-authorship network of co-authors of Damian Harding

This figure shows the co-authorship network connecting the top 25 collaborators of Damian Harding. A scholar is included among the top collaborators of Damian Harding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damian Harding. Damian Harding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Sukocheva, Olga, et al.. (2025). Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives. World Journal of Hepatology. 17(7). 106675–106675. 1 indexed citations
2.
Chan, Andrew T., Hamish Philpott, Amanda Lim, et al.. (2020). Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence. World Journal of Gastrointestinal Endoscopy. 12(11). 408–450. 1 indexed citations
3.
Wigg, Alan, Kate Muller, Jeyamani Ramachandran, et al.. (2018). Real‐world outcomes of unrestricted direct‐acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience. Journal of Viral Hepatitis. 25(11). 1287–1297. 26 indexed citations
4.
Harding, Damian, et al.. (2018). Gastrointestinal: Olmesartan‐induced enteropathy. Journal of Gastroenterology and Hepatology. 33(10). 1691–1691. 6 indexed citations
5.
Bernal, William, Yanzhong Wang, Christopher Willars, et al.. (2016). Development and validation of a dynamic outcome prediction model for paracetamol-induced acute liver failure: a cohort study. ˜The œLancet. Gastroenterology & hepatology. 1(3). 217–225. 33 indexed citations
6.
Harding, Damian, M. Thamara P. R. Perera, Frederick Chen, Simon Olliff, & Dhiraj Tripathi. (2015). Portal vein thrombosis in cirrhosis: Controversies and latest developments. World Journal of Gastroenterology. 21(22). 6769–6784. 69 indexed citations
7.
Harding, Damian, Gerry MacQuillan, Rebecca Howman, et al.. (2014). Successful Use of Dasatinib After Liver Transplantation for Imatinib-Induced Fulminant Liver Failure in Chronic Myeloid Leukemia. Journal of Clinical Oncology. 34(11). e97–e98. 5 indexed citations
8.
Harding, Damian, Kavitha Subramaniam, Gerry MacQuillan, Joshua S. Davis, & David Nolan. (2012). Severe drug‐induced hypersensitivity syndrome with a shared HLA‐B allele. The Medical Journal of Australia. 197(7). 411–413. 12 indexed citations
9.
Hajdenberg, Julio, et al.. (2007). Evaluation of VEGF targeted therapy efficacy in mRCC after sorafenib failure or intolerance. Journal of Clinical Oncology. 25(18_suppl). 15517–15517. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alisa Likhitsup Breakdown of academic impact, for papers by Sonia Berardi Breakdown of academic impact, for papers by Laura Cisneros Breakdown of academic impact, for papers by Kate D. Lynch Breakdown of academic impact, for papers by Zeeshan Ahmad Wani Breakdown of academic impact, for papers by Sandra Saldana Breakdown of academic impact, for papers by Amol S. Rangnekar Breakdown of academic impact, for papers by Sheila Eswaran Breakdown of academic impact, for papers by H. H. Dahm Breakdown of academic impact, for papers by Miquel Sanz
Rankless by CCL
2026